Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jun-23 10:00 PM View:  | Ligand Pharmaceuticals Inc. (LGND) | 09-Jun-23 | Grant | 1,142 | -- | -- | 4% 27.12K to 28.26K | |
| 17-Jan-23 6:29 AM View: | Immunome Inc. (IMNM) | 15-Jan-23 | Grant | 15,125 | $4.00 | $60,500.00 | 29% 51.83K to 66.95K | |
| 13-Jun-22 6:45 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 1,004 | -- | -- | 4% 25.4K to 26.4K | |
| 17-Nov-21 5:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Nov-21 | Option Exercise | 4,835 | $32.30 | $156,170.00 | 19% 25.4K to 30.23K | |
| 17-Nov-21 5:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 16-Nov-21 | Market Option Sale | 4,835 | $161.86 | $782,579.00 | (16%) 30.23K to 25.4K | |
| 07-Jun-21 9:24 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-21 | Grant | 630 | -- | -- | 3% 24.77K to 25.4K | |
| 26-May-21 9:26 PM View: | Immunome Inc. (IMNM) | 24-May-21 | Market Purchase | 5,440 | $18.57 | $101,028.00 | 12% 46.39K to 51.83K | (< 1%) |
| 08-Oct-20 6:11 PM View: | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 46,388 | -- | -- | 100% 0 to 46.39K | |
| 12-Jun-20 6:32 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-20 | Grant | 831 | -- | -- | 3% 23.94K to 24.77K | |
| 05-Aug-19 7:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Aug-19 | Payment of Exercise | 847 | $95.58 | $80,958.30 | (3%) 24.78K to 23.94K | (36%) |
| 05-Aug-19 7:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Aug-19 | Option Exercise | 2,500 | $32.30 | $80,750.00 | 11% 22.28K to 24.78K | |
| 07-Jun-19 6:46 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 06-Jun-19 | Grant | 835 | -- | -- | 4% 21.45K to 22.28K | |
| 28-Jan-19 7:01 PM View: | Larimar Therapeutics, Inc. (LRMR) | 24-Jan-19 | Grant | 10,844 | $4.38 | $47,496.70 | 53% 20.53K to 31.38K | 195% |
| 05-Sep-18 7:59 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Sep-18 | Option Exercise | 3,335 | $12.53 | $41,787.60 | 16% 21.45K to 24.78K | |
| 05-Sep-18 7:59 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Sep-18 | Market Option Sale (Planned) | 3,335 | $254.96 | $850,292.00 | (13%) 24.78K to 21.45K | 49% |
| 21-Jun-18 4:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 19-Jun-18 | Grant | 493 | -- | -- | 2% 20.96K to 21.45K | |
| 04-Jun-18 7:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-18 | Option Exercise | 4,000 | $12.53 | $50,120.00 | 19% 20.96K to 24.96K | |
| 04-Jun-18 7:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-18 | Market Option Sale (Planned) | 4,000 | $194.51 | $778,039.00 | (16%) 24.96K to 20.96K | 33% |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Mar-18 | Option Exercise | 3,335 | $10.12 | $33,750.20 | 16% 20.96K to 24.29K | |
| 06-Mar-18 6:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Mar-18 | Market Option Sale (Planned) | 3,335 | $160.90 | $536,604.00 | (14%) 24.29K to 20.96K | 19% |
| 05-Jan-18 5:01 PM View: | Larimar Therapeutics, Inc. (LRMR) | 03-Jan-18 | Grant | 9,169 | $5.18 | $47,495.40 | 81% 11.36K to 20.53K | 150% |
| 17-Nov-17 7:19 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Nov-17 | Option Exercise | 4,000 | $10.12 | $40,480.00 | 19% 20.96K to 24.96K | |
| 17-Nov-17 7:19 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 17-Nov-17 | Market Option Sale | 4,000 | $139.79 | $559,160.00 | (16%) 24.96K to 20.96K | 7% |
| 26-May-17 8:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 25-May-17 | Grant | 666 | -- | -- | 3% 20.29K to 20.96K | |
| 14-Feb-17 8:07 PM View: | Larimar Therapeutics, Inc. (LRMR) | 13-Feb-17 | Grant | 11,363 | $4.18 | $47,497.30 | 100% 0 to 11.36K | 209% |
| 25-May-16 7:17 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-May-16 | Grant | 810 | -- | -- | 4% 19.48K to 20.29K | |
| 13-Nov-15 5:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 12-Nov-15 | Gift | 1,500 | -- | -- | (7%) 20.98K to 19.48K | |
| 27-Apr-15 7:55 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Apr-15 | Grant | 925 | -- | -- | 5% 20.05K to 20.98K | |
| 26-Nov-14 3:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 24-Nov-14 | Gift | 2,785 | -- | -- | (12%) 22.84K to 20.05K | |
| 05-Jun-14 4:47 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-14 | Grant | 1,484 | -- | -- | 7% 21.36K to 22.84K | |
| 20-Mar-14 6:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 18-Mar-14 | Option Exercise | 5,000 | $8.97 | $44,850.00 | 23% 21.36K to 26.36K | |
| 20-Mar-14 6:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 18-Mar-14 | Market Option Sale | 5,000 | $78.83 | $394,150.00 | (19%) 26.36K to 21.36K | (65%) |
| 21-Nov-13 4:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 20-Nov-13 | Gift | 3,800 | -- | -- | (15%) 25.16K to 21.36K | |
| 12-Jun-13 5:12 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Jun-13 | Grant | 3,621 | -- | -- | 17% 21.54K to 25.16K | |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition | 4,166 | $14.25 | $59,365.50 | (9%) 47.01K to 42.84K | < 1% |
| 01-Aug-12 1:57 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 42,843 | $14.25 | $610,513.00 | (100%) 42.84K to 0 | < 1% |
| 31-May-12 7:40 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 31-May-12 | Grant | 4,721 | -- | -- | 28% 16.81K to 21.54K | |
| 21-May-12 9:41 AM View: | Human Genome Sciences Inc. (HGSI) | 17-May-12 | Grant | 2,500 | -- | -- | 6% 44.51K to 47.01K | |
| 11-Aug-11 5:05 PM View: | Human Genome Sciences Inc. (HGSI) | 10-Aug-11 | Option Exercise | 12,009 | $2.09 | $25,098.80 | 37% 32.5K to 44.51K | |
| 03-Jun-11 3:19 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Jun-11 | Grant | 5,148 | -- | -- | 44% 11.67K to 16.81K | |
| 16-May-11 11:52 AM View: | Human Genome Sciences Inc. (HGSI) | 12-May-11 | Grant | 2,500 | -- | -- | 8% 30.0K to 32.5K | |
| 14-Mar-11 4:12 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 11-Mar-11 | Market Purchase | 10,000 | $9.80 | $98,029.70 | 600% 1.67K to 11.67K | 1229% |
| 10-Feb-11 3:29 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 07-Feb-11 | Grant | 1,666 | -- | -- | 100% 0 to 1.67K | |
| 16-Mar-09 5:13 PM View: | Human Genome Sciences Inc. (HGSI) | 13-Mar-09 | Market Purchase | 10,000 | $0.72 | $7,194.37 | 50% 20.0K to 30.0K | 3283% |
| 13-Nov-08 10:02 AM View: | Human Genome Sciences Inc. (HGSI) | 12-Nov-08 | Market Purchase | 20,000 | $2.19 | $43,773.00 | 100% 0 to 20.0K | 1010% |
| 03-Jul-07 10:45 AM View: | Pfizer Inc. (PFE) | 29-Jun-07 | Payment of Exercise | 6,264 | $25.57 | $160,170.00 | (1%) 448.51K to 442.24K | (75%) |
| 18-Jun-07 4:38 PM View: | Pfizer Inc. (PFE) | 15-Jun-07 | Gift | 40,000 | -- | -- | (8%) 524.58K to 484.57K | |
| 18-Jun-07 4:38 PM View: | Pfizer Inc. (PFE) | 15-Jun-07 | Market Sale | 36,066 | $26.48 | $955,028.00 | (7%) 484.57K to 448.51K | (69%) |
| 27-Mar-07 4:06 PM View: | Pfizer Inc. (PFE) | 23-Mar-07 | Payment of Exercise | 13,710 | $25.66 | $351,799.00 | (3%) 534.06K to 520.35K | (76%) |
| 26-Feb-07 5:12 PM View: | Pfizer Inc. (PFE) | 22-Feb-07 | Grant | 73,770 | -- | -- | 15% 479.65K to 553.42K |